Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 54,451 followers.

ORIGINAL RESEARCH article! Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia! https://t.co/OtBwzK87mp https://t.co/tbcyUxYAwj

02 Nov 2022

Reply Repost Favourite

Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia https://t.co/w2m8ggRcLG https://t.co/PviQRSyiOf

02 Nov 2022

Reply Repost Favourite

New Research: Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia: The management of relapsed or refractory acute myeloid leukemia (AML) continues to be therapeutically challenging. Non-toxic immunotherapy approaches are… https://t.co/Ya

02 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.